<?xml version="1.0" encoding="UTF-8"?>
<ref id="B100">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Quintão</surname>
    <given-names>N. L. M.</given-names>
   </name>
   <name>
    <surname>Santin</surname>
    <given-names>J. R.</given-names>
   </name>
   <name>
    <surname>Stoeberl</surname>
    <given-names>L. C.</given-names>
   </name>
   <name>
    <surname>Corrêa</surname>
    <given-names>T. P.</given-names>
   </name>
   <name>
    <surname>Melato</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Costa</surname>
    <given-names>R.</given-names>
   </name>
  </person-group> (
  <year>2019</year>). 
  <article-title>Pharmacological treatment of chemotherapy-induced neuropathic pain: PPARγ agonists as a promising tool</article-title>. 
  <source>Front. Neurosci.</source>
  <volume>13</volume>, 
  <fpage>1</fpage>–
  <lpage>17</lpage>. 
  <pub-id pub-id-type="doi">10.3389/fnins.2019.00907</pub-id>.
  <pub-id pub-id-type="pmid">30740042</pub-id>
 </mixed-citation>
</ref>
